Literature DB >> 15161011

Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression.

Masayuki Kojima1, Takashi Morisaki, Nobuhiko Sasaki, Kenji Nakano, Ryuichi Mibu, Masao Tanaka, Mitsuo Katano.   

Abstract

OBJECTIVES: Nuclear factor-kB (NF-kB) is a transcription factor that participates in the induction of several genes for cytokines and enzymes that play important functional roles in various cell types. The aim of this study was to determine NF-kB activation status in human colorectal carcinoma and its correlation to the clinicopathological characteristics of patients.
MATERIALS AND METHODS: We examined the activation status of NF-kB in 28 resected colorectal carcinomas and in colonic mucosa from uninvolved portions of these specimens by electrophoretic mobility shift assay (EMSA) and immunohistochemical staining for the p65 subunit of NF-kB.
RESULTS: EMSA showed much greater activation in the tumors than in normal mucosa, as did epithelial p65 immunostaining. NF-kB activation significantly increased in the more progressed cases (T3 + T4 cases or Stage II< cases). In vitro studies using lipopolysaccharide (LPS)-responsive colon carcinoma cells suggested a correlation between NF-kB activation and cell proliferation.
CONCLUSION: Our findings indicated that NF-kB is constitutively activated in human colorectal carcinoma tissue and correlates with tumor progression. The regulation of this transcription factor might be therapeutically useful against these tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161011

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  59 in total

1.  The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death.

Authors:  Seung-Joo Lee; Meixiao Long; Adam J Adler; Robert S Mittler; Anthony T Vella
Journal:  J Leukoc Biol       Date:  2008-10-15       Impact factor: 4.962

2.  Different cellular localization of NF-κB p65 expression as an indicator of different prognoses of stage I-III gastric cancer patients.

Authors:  Fang Zhou; Hongjun Wei; Aiping Ding; Wensheng Qiu; Lingxin Feng; Quan Zhou; Jun Liang; Lu Yue
Journal:  Clin Transl Sci       Date:  2013-05-08       Impact factor: 4.689

3.  Expression profile of NF-κB regulated genes in sporadic colorectal cancer patients.

Authors:  Betsy Annel González-Quezada; Uriel Francisco Santana-Bejarano; Alfredo Corona-Rivera; Helia Judith Pimentel-Gutiérrez; Rocío Silva-Cruz; Citlalli Ortega-De-la-Torre; Ramón Franco-Topete; Karina Franco-Topete; Manuel Willebaldo Centeno-Flores; Víctor Manuel Maciel-Gutiérrez; Jorge Román Corona-Rivera; Juan Armendáriz-Borunda; Lucina Bobadilla-Morales
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

4.  Daikenchuto (TU-100) Suppresses Tumor Development in the Azoxymethane and APCmin/+ Mouse Models of Experimental Colon Cancer.

Authors:  Takumu Hasebe; Jun Matsukawa; Daina Ringus; Jun Miyoshi; John Hart; Atsushi Kaneko; Masahiro Yamamoto; Toru Kono; Mikihiro Fujiya; Yutaka Kohgo; Chong-Zi Wang; Chun-Su Yuan; Marc Bissonnette; Mark W Musch; Eugene B Chang
Journal:  Phytother Res       Date:  2016-10-12       Impact factor: 5.878

5.  NF-κB pathway in colitis-associated cancers.

Authors:  Emilie Viennois; Fengyuan Chen; Didier Merlin
Journal:  Transl Gastrointest Cancer       Date:  2013-01-01

6.  Homeobox protein CDX2 reduces Cox-2 transcription by inactivating the DNA-binding capacity of nuclear factor-kappaB.

Authors:  Hiroyuki Mutoh; Hiroko Hayakawa; Hirotsugu Sakamoto; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

7.  A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.

Authors:  Sanhong Liu; Xiaohua Sun; Mingliang Wang; Yingyong Hou; Yu Zhan; Yuhang Jiang; Zhanjie Liu; Xinwei Cao; Pengfei Chen; Zhi Liu; Xi Chen; Yu Tao; Chen Xu; Jie Mao; Chunyan Cheng; Cuifeng Li; Yiming Hu; Lunshan Wang; Y Eugene Chin; Yufang Shi; Ulrich Siebenlist; Xiaoren Zhang
Journal:  Gastroenterology       Date:  2014-06-12       Impact factor: 22.682

8.  Expression of NF-κB and PTEN in primary epithelial ovarian carcinoma and the correlation with chemoresistance.

Authors:  Lili Wang; Chenxu Wang; Shanshan Jin; Donghui Qu; Huanchun Ying
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity.

Authors:  Daniela Sorriento; Alfonso Campanile; Gaetano Santulli; Eleonora Leggiero; Lucio Pastore; Bruno Trimarco; Guido Iaccarino
Journal:  Mol Cancer       Date:  2009-11-09       Impact factor: 27.401

10.  Characterization of anti-NF-kappaB RNA aptamer-binding specificity in vitro and in the yeast three-hybrid system.

Authors:  Susan E Wurster; John Paul Bida; Yeng F Her; L James Maher
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.